Aida Jared, Chau Brian, Dunn Justin
Department of Physical Medicine and Rehabilitation, Loma Linda University Health, Loma Linda, CA, USA.
Department of Veteran Affairs, Loma Linda Healthcare System, Department of Physical Medicine and Rehabilitation, Redlands, CA, USA.
NeuroRehabilitation. 2018;42(4):441-448. doi: 10.3233/NRE-172361.
Traumatic brain injury (TBI) is a common cause of morbidity and mortality in the United States with its sequelae often affecting individuals long after the initial injury. Innovations in virtual reality (VR) technology may offer potential therapy options in the recovery from such injuries. However, there is currently no consensus regarding the efficacy of VR in the setting of TBI rehabilitation.
The aim of this review is to evaluate and summarize the current literature regarding immersive VR in the rehabilitation of those with TBI.
A comprehensive literature search was conducted utilizing PubMed, Google Scholar, and the Cochrane Review using the search terms "virtual reality," "traumatic brain injury," "brain injury," and "immersive."
A total of 11 studies were evaluated. These were primarily of low-level evidence, with the exception of two randomized, controlled trials. 10 of 11 studies demonstrated improvement with VR therapy. VR was most frequently used to address gait or cognitive deficits.
While the current literature generally offers support for the use of VR in TBI recovery, there is a paucity of strong evidence to support its widespread use. The increasing availability of immersive VR technology offers the potential for engaging therapy in TBI rehabilitation, but its utility remains uncertain given the limited studies available at this time.
创伤性脑损伤(TBI)是美国发病和死亡的常见原因,其后遗症往往在初次受伤后很长时间仍会影响个体。虚拟现实(VR)技术的创新可能为这类损伤的康复提供潜在的治疗选择。然而,目前关于VR在TBI康复中的疗效尚无共识。
本综述的目的是评估和总结目前关于沉浸式VR在TBI患者康复中的文献。
利用PubMed、谷歌学术和考克兰系统评价数据库进行全面的文献检索,检索词为“虚拟现实”、“创伤性脑损伤”、“脑损伤”和“沉浸式”。
共评估了11项研究。除两项随机对照试验外,这些研究主要为低水平证据。11项研究中有10项表明VR治疗有改善效果。VR最常用于解决步态或认知缺陷问题。
虽然目前的文献总体上支持在TBI恢复中使用VR,但缺乏有力证据支持其广泛应用。沉浸式VR技术的日益普及为TBI康复中的参与性治疗提供了潜力,但鉴于目前可用的研究有限,其效用仍不确定。